Bevacizumab and pneumonia Patient Reports February 09, 2010

Bevacizumab Side Effects Report #4775284-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2005. Male patient, weighting 181.0 lb, was diagnosed with transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia , pseudomonas infection, sputum culture positive, white blood cell count decreased. Bevacizumab dosage: 15MG.KG EVERY 3 WEEKS IV. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5662110-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia , respiratory arrest. Bevacizumab dosage: 15 MG/KG, SINGLE. During the same period patient was treated with CISPLATIN, GLYBURIDE, GUAIFENESIN, LISINOPRIL, ONDANSETRON, PIOGLITAZONE. Patient was hospitalized. Patient died on 02/15/2008.

Bevacizumab Side Effects Report #5726497-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 18, 2008. Female patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, OXYCONTIN, LASIX, DECADRON, ZOFRAN. Patient was hospitalized. Patient died on 01/29/2008.

Bevacizumab Side Effects Report #5951452-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 11, 2008. Female patient, 94 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: liver abscess, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.


Bevacizumab Side Effects Report #6023686-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 73 years of age, weighting 180.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, pneumonia , pneumonitis, productive cough, pulmonary toxicity. Bevacizumab dosage: 835MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient died on 12/19/2008.

Bevacizumab Side Effects Report #5941598-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 68 years of age, weighting 213.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 1000MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5989998-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 09, 2008. Male patient, 68 years of age, weighting 213.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter related infection, pneumonia , tachycardia. Bevacizumab dosage: 1000MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5787325-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 23, 2008. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atelectasis, inflammation, pleural effusion, pneumonia . Bevacizumab dosage: 630 MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL, LOVAQUIN. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5959779-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2008. Female patient, 61 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: liver abscess, pneumonia . Bevacizumab dosage: 630MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.


Bevacizumab Side Effects Report #5960281-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 18, 2008. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration pleural cavity abnormal, atelectasis, dyspnoea, inflammation, pleural effusion, pneumonia . Bevacizumab dosage: 630MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL, LOVAQUIN. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5938601-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 27, 2008. Male patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, MAXOLON, NAVOBAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5608463-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 22, 2008. Male patient, weighting 214.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, leukocytosis, pneumonia . Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with PACLITAXEL, CISPLATIN, FLUOROURACIL, AMIODARONE, ATORVASTATIN, INULIN, LOPRESSOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5698386-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 01, 2008. Male patient, weighting 214.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, leukocytosis, pneumonia . Bevacizumab dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with PACLITAXEL, CISPLATIN, FLUOROURACIL, AMIODARONE, ATORVASTATIN, INULIN, LOPRESSOR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5892936-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2008. Male patient, 58 years of age, weighting 181.0 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5955143-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2008. Female patient, weighting 131.0 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, chronic obstructive pulmonary disease, heart rate increased, oropharyngeal pain, pleural effusion, pneumonia . Bevacizumab dosage: 15MG/KG Q3WEEKS 041. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #4939196-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2006. Male patient, 66 years of age, weighting 172.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: decreased appetite, disease progression, dry mouth, malignant neoplasm progression, multi-organ failure, non-small cell lung cancer metastatic, pneumonia , pneumonia viral, pneumonitis. Bevacizumab dosage: 15 MG/KG Q 21 DAYS IV. During the same period patient was treated with PEMETREXED ELI LILY, FOLATE, ATIVAN, ZOLOFT, DIGOXIN, COMPAZINE, ATENOLOL, ALLEGRA. Patient was hospitalized. Patient died on 03/03/2006.

Bevacizumab Side Effects Report #6039223-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 08, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient died on 04/08/2007.

Bevacizumab Side Effects Report #6075890-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 05, 2009. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis , pneumonia , vomiting. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, DOCETAXEL, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5295505-8
Bevacizumab side effect was reported by a Physician from BRAZIL on Mar 20, 2007. Male patient, 43 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, dialysis , pneumonia , renal failure acute. Bevacizumab dosage: 1185 MG, Q3W, INTRAVENOUS. During the same period patient was treated with VINORELBINE TARTRATE, LEVOTHYROXINE, CARDURAN, STARLIX, METFORMIN, AMITRIL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5301509-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.

Bevacizumab Side Effects Report #5312790-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.

Bevacizumab Side Effects Report #5487181-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chills, disease progression, muscular weakness, neutropenic infection, neutrophil count decreased, pneumonia . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ERBITUX, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5529641-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 19, 2007. Male patient, weighting 201.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, DUONEB, TYLOX, PROTONIX, MAXIPIME. Patient died on 09/22/2007.

Bevacizumab Side Effects Report #5715003-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 08, 2008. Male patient, weighting 142.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood urea increased, pancytopenia, pneumonia . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, ALVEDON, OMEPRAZOLE, MOVICOL, FRAGMIN, OXYCONTIN, HALDOL. Patient was hospitalized. Patient died on 03/13/2008.


Bevacizumab Side Effects Report #5744655-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 08, 2008. Male patient, weighting 142.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, ALVEDON, OMEPRAZOLE, NULYTELY, FRAGMIN, OXYCONTIN, HALDOL. Patient was hospitalized. Patient died on 03/13/2008.

Bevacizumab Side Effects Report #5841856-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 29, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pancreatitis acute, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5886547-X
Bevacizumab side effect was reported by a Physician from GERMANY on Sept 10, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 1260 MG, Q3W. During the same period patient was treated with ERLOTINIB, UNACID. Patient was hospitalized. Patient died on 01/04/2008.

Bevacizumab Side Effects Report #5929928-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia . Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 10/05/2007.

Bevacizumab Side Effects Report #5936274-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 17, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis acute, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMZAR, CARBOPLATIN, AUGMENTIN, KLACID, CEFEPIME, VANCOMYCIN HYDROCHLORIDE, AMOXICILLIN. Patient was hospitalized. Patient died on 09/21/2008.


Bevacizumab Side Effects Report #5944151-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient, weighting 101.4 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, dehydration, haemoglobin decreased, hypoproteinaemia, pneumonia . Bevacizumab dosage: 634 MG, Q3W. During the same period patient was treated with ENALAPRIL MALEATE, CLONIDINE, BROMAZEPAM, VERAPAMIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5949240-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient, weighting 142.0 lb, was diagnosed with non-small cell lung cancer, anxiety , pain , pneumonia , nausea  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastroenteritis , pneumonia . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ALIMTA, GEMZAR, XANAX, LORTAB, PROTONIX, LEVAQUIN, PERCOCET, PHENERGAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5965107-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter sepsis, cholelithiasis, disease progression, enterococcal sepsis, gastric neoplasm, pancreatitis acute, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMZAR, CARBOPLATIN, AUGMENTIN, KLACID, CEFEPIME, VANCOMYCIN, AMOXICILLIN. Patient recovered.

Bevacizumab Side Effects Report #6025568-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 02, 2008. Female patient, weighting 142.0 lb, was diagnosed with non-small cell lung cancer, anxiety , pain , pneumonia , nausea  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastroenteritis , platelet count decreased, pneumonia , rectal polyp. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with ALIMTA, GEMZAR, XANAX, LORTAB, PROTONIX, LEVAQUIN, PERCOCET, PHENERGAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6135779-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 12, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 680 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, PANTOPRAZOLE, CARBIMAZOL. Patient was hospitalized. Patient died on 01/03/2009.


Bevacizumab Side Effects Report #6004356-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2008. Female patient was diagnosed with neuroblastoma  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with LIOTHYRONINE, POTASSIUM IODIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6045905-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 13, 2009. Male patient, 68 years of age, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, lymphopenia, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5647794-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia , respiratory arrest. Bevacizumab dosage: unknown. During the same period patient was treated with CISPLATIN, GLYBURIDE, GUAIFENESIN, LISINOPRIL, ONDANSETRON, PIOGLITAZONE, SIMVASTATIN. Patient was hospitalized. Patient died on 02/15/2008.

Bevacizumab Side Effects Report #5225749-2
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 31, 2007. Male patient, 63 years of age, weighting 149.0 lb, was diagnosed with neoplasm malignant, constipation  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , constipation , flatulence, haemoptysis, pneumonia , purulence. Bevacizumab dosage: 15 MG/KG EVERY 3 WEEKS. During the same period patient was treated with BUBBLE GUM ENEMA, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5143840-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Male patient, 56 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, dehydration, hiccups, nausea , pneumonia . Bevacizumab dosage: 812MG WKS 1,3,5 DELAYED. During the same period patient was treated with CISPLATIN, ERLOTINIB, ZOFRAN, DULCOLAX, DECADRON. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5211798-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2007. Male patient, 49 years of age, weighting 206.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: chest pain , pneumonia . Bevacizumab dosage: 937 MG Q 14 DAYS IV. During the same period patient was treated with PROLEUKIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6106591-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 26, 2009. Female patient, weighting 140.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hepatic enzyme increased, multi-organ failure, pneumonia , pulmonary embolism , renal failure acute. Bevacizumab dosage: 667 MG, Q2W. During the same period patient was treated with METOPROLOL, ALTACE, XANAX, CALCIUM, CRESTOR, ZOFRAN. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #4594920-5
Bevacizumab side effect was reported by a Health Professional from on Feb 01, 2005. Female patient, 55 years of age, was diagnosed with metastatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain , caecitis, colitis, large intestine perforation, pneumonia , serositis. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5208329-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2007. Male patient, weighting 156.5 lb, was diagnosed with mesothelioma  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: impaired work ability, incision site complication, infection , inflammation, lung neoplasm, neoplasm malignant, pneumonia , weight decreased. Bevacizumab dosage: 1084MG Q 21 DAYS IV. During the same period patient was treated with ERLOTINIB, LEVOFLOXACIN, AMBIEN, LIPITOR, METAMUCIL, VITAMIN E, XANAX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5949170-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 28, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5967237-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 13, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5977998-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 18, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5990946-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 27, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012580-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 04, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6025053-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 18, 2008. Male patient was diagnosed with lung neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Bevacizumab dosage: 15.6 ML, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, RISPERIDONE, CARBAMAZEPINE, BROMAZEPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5124722-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Male patient, 59 years of age, weighting 184.3 lb, was diagnosed with laryngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection , hypoglycaemia, hypotension, liver disorder, myocardial infarction, pneumonia , renal failure, septic shock. Bevacizumab dosage: 361 MG IV. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5287046-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 23, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abnormal behaviour, deep vein thrombosis , hydrocephalus , neutrophil count decreased, pneumonia , pulmonary embolism , urinary tract infection . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, LEVAQUIN, THIAMINE HYDROCHLORIDE, DEXAMETHASONE, HEPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5819897-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 15, 2008. Female patient, 57 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral ischaemia, pneumonia , thrombocytopenia. Bevacizumab dosage: unknown. During the same period patient was treated with ENZASTAURIN, KEPPRA, DEXAMETHASONE, OMEPRAZOLE. Patient was hospitalized. Patient died on 02/23/2002.

Bevacizumab Side Effects Report #5477706-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disease progression, fall , hemiparesis, hypotension, lung neoplasm, pneumonia , tachycardia. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5297826-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, disease progression, fall , hyponatraemia, nausea , pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5301842-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, fall , hyponatraemia, malignant neoplasm progression, nausea , nuclear magnetic resonance imaging brain abnormal, pneumonia , somnolence. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, PREVACID, RITALIN, KEPPRA, DECADRON, LOVASTATIN, COLACE. Patient was hospitalized. Patient died on 04/13/2007.

Bevacizumab Side Effects Report #5443243-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient, weighting 194.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia . Bevacizumab dosage: 10MG/M2 D1 + D15 Q CYCLE IV. During the same period patient was treated with ETOPOSIDE, DECADRON, ZANTAC, CELEXA. Patient died on 06/30/2007.

Bevacizumab Side Effects Report #5932865-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2008. Male patient, 69 years of age, weighting 130.1 lb, was diagnosed with gastrooesophageal cancer, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal perforation, oesophageal fistula, pneumonia . Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5239007-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 30, 2007. Male patient, 63 years of age, weighting 183.0 lb, was diagnosed with gallbladder cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac failure congestive, pneumonia , respiratory failure. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5875666-X
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, weighting 132.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bronchospasm, palmar-plantar erythrodysaesthesia syndrome, pneumonia . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN, INSULIN. Patient died on 06/17/2008.


Bevacizumab Side Effects Report #5938193-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonia . Bevacizumab dosage: 430 MG, Q21D. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, OMNIC, LANSOPRAZOLE. Patient was hospitalized. Patient died on 10/13/2008.

Bevacizumab Side Effects Report #5955405-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with colorectal cancer , colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: confusional state, pneumonia , pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6123520-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 03, 2009. Female patient was diagnosed with colorectal cancer  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, pneumonia . Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, DURAGESIC, GLIMEPIRIDE, MACROGOL, NAPROXEN, PANTOPRAZOLE, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/20/2006.

Bevacizumab Side Effects Report #5725661-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 18, 2008. Male patient was diagnosed with colon cancer recurrent, pain  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, pneumonia . Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, MS CONTIN, MORPHINE ELIXIR, KYTRIL, DECADRON, HALOPERIDOL. Patient died on 12/10/2007.

Bevacizumab Side Effects Report #5754671-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 16, 2008. Male patient was diagnosed with colon cancer recurrent, pain  and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, pneumonia , renal failure. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, MS CONTIN, MORPHINE ELIXIR, KYTRIL, DECADRON, HALOPERIDOL. Patient died on 01/02/2008.

Bevacizumab Side Effects Report #5489940-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 03, 2007. Female patient, weighting 187.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia , pulmonary granuloma. Bevacizumab dosage: 654 MG, Q3W. During the same period patient was treated with ACTOS, LIPITOR, ASPIRIN, AMARYL, VITAMIN, PROPOXYPHENE HYDROCHLORIDE, DRAMAMINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5501083-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 16, 2007. Female patient, weighting 187.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia , pulmonary granuloma. Bevacizumab dosage: 654 MG, Q3W. During the same period patient was treated with ACTOS, LIPITOR, ASPIRIN, AMARYL, VITAMIN, PROPOXYPHENE HYDROCHLORIDE, DRAMAMINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5754672-X
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on May 16, 2008. Male patient was diagnosed with colon cancer, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiac arrest , catheter thrombosis, gastrointestinal haemorrhage, lung disorder, neuropathy peripheral, pneumonia , venous thrombosis. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with HEPARIN, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, IRINOTECAN. Patient died on 05/13/2008.

Bevacizumab Side Effects Report #5794200-6
Bevacizumab side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2008. Male patient was diagnosed with colon cancer, metastases to liver and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, lung disorder, pneumonia , venous thrombosis. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with HEPARIN, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, IRINOTECAN. Patient died on 05/13/2008.

Bevacizumab Side Effects Report #5875230-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 25, 2008. Male patient, weighting 153.7 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, ileus paralytic, pneumonia , staphylococcal sepsis. Bevacizumab dosage: 523 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, ZOCOR, ADALAT. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #6124391-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, 71 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 700 MG, UNK. During the same period patient was treated with NEUPOGEN, PERCOCET, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5567154-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 13, 2007. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, blood ph increased, mental status changes, pneumonia , pulmonary embolism , renal disorder, sputum discoloured. Bevacizumab dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient died on 12/04/2007.

Bevacizumab Side Effects Report #5600213-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic, non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, hypoxia, mental status changes, oesophageal ulcer, oesophagitis, oxygen saturation decreased, pneumonia , radiation injury. Bevacizumab dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5834555-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 22, 2008. Female patient, weighting 195.1 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumonia . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, TENORETIC, CIPRO, STILNOX, LASIX, POTASSIUM CHLORIDE, NEXIUM. Patient was hospitalized. Patient died on 05/18/2007.

Bevacizumab Side Effects Report #5977885-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 18, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, pleural effusion, pneumonia , pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with TAXOTERE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5978092-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 18, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonia , pyrexia. Bevacizumab dosage: 1000 MG, Q3W. During the same period patient was treated with TAXOTERE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5885511-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 01, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cardiogenic shock, metabolic acidosis, pneumonia . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with VORICONAZOLE, FUROSEMIDE, PROPRANOLOL, NEXIUM, CLEMASTINE FUMARATE, COLISTIN SULPHATE, LORAZEPAM, KYTRIL. Patient recovered.

Bevacizumab Side Effects Report #5477521-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 05, 2007. Male patient, 72 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia , pneumopericardium. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, SIMETHICONE, MS CONTIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5506928-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 22, 2007. Male patient, 72 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia , pneumopericardium. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, SIMETHICONE, MS CONTIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5542617-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 04, 2007. Male patient, 72 years of age, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia , pneumopericardium. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, SIMETHICONE, MS CONTIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5015292-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 30, 2006. Female patient, 51 years of age, weighting 144.0 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypotension, neutrophil count increased, pain , pneumonia , sepsis , urine leukocyte esterase positive. Bevacizumab dosage: BEVACIZUMAB 10MG/KG. During the same period patient was treated with TARCEVA, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5920138-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2008. Female patient, weighting 206.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: medical device complication, pneumonia . Bevacizumab dosage: 920 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, NEULASTA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5958546-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 04, 2008. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, pneumonia . Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with VANDETANIB. Patient was hospitalized. Patient recovered.